ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/20 | 3,250 | 3,265 | 3,150 | 3,160 | -115 | -3.5% | 167,900 |
2018/12/19 | 3,275 | 3,305 | 3,265 | 3,275 | -40 | -1.2% | 126,700 |
2018/12/18 | 3,390 | 3,405 | 3,315 | 3,315 | -135 | -3.9% | 147,700 |
2018/12/17 | 3,445 | 3,460 | 3,415 | 3,450 | -35 | -1% | 116,300 |
2018/12/14 | 3,515 | 3,525 | 3,465 | 3,485 | -30 | -0.9% | 194,200 |
2018/12/13 | 3,495 | 3,525 | 3,485 | 3,515 | +25 | +0.7% | 190,200 |
2018/12/12 | 3,430 | 3,500 | 3,425 | 3,490 | +80 | +2.3% | 178,800 |
2018/12/11 | 3,445 | 3,470 | 3,380 | 3,410 | -10 | -0.3% | 173,300 |
2018/12/10 | 3,470 | 3,470 | 3,410 | 3,420 | -50 | -1.4% | 162,000 |
2018/12/07 | 3,435 | 3,475 | 3,410 | 3,470 | +65 | +1.9% | 176,700 |
2018/12/06 | 3,485 | 3,505 | 3,395 | 3,405 | -145 | -4.1% | 161,600 |
2018/12/05 | 3,470 | 3,550 | 3,465 | 3,550 | +55 | +1.6% | 191,500 |
2018/12/04 | 3,500 | 3,515 | 3,480 | 3,495 | -45 | -1.3% | 200,500 |
2018/12/03 | 3,585 | 3,590 | 3,525 | 3,540 | +25 | +0.7% | 173,500 |
2018/11/30 | 3,510 | 3,515 | 3,460 | 3,515 | +75 | +2.2% | 303,200 |
2018/11/29 | 3,425 | 3,470 | 3,420 | 3,440 | +10 | +0.3% | 185,600 |
2018/11/28 | 3,425 | 3,445 | 3,400 | 3,430 | +30 | +0.9% | 130,200 |
2018/11/27 | 3,425 | 3,435 | 3,390 | 3,400 | -20 | -0.6% | 160,800 |
2018/11/26 | 3,405 | 3,445 | 3,405 | 3,420 | +20 | +0.6% | 187,800 |
2018/11/22 | 3,375 | 3,400 | 3,340 | 3,400 | ±0 | ±0% | 190,400 |
2018/11/21 | 3,415 | 3,450 | 3,400 | 3,400 | -95 | -2.7% | 183,000 |
2018/11/20 | 3,500 | 3,540 | 3,465 | 3,495 | -35 | -1% | 283,000 |
2018/11/19 | 3,430 | 3,540 | 3,430 | 3,530 | +100 | +2.9% | 306,200 |
2018/11/16 | 3,410 | 3,435 | 3,390 | 3,430 | +10 | +0.3% | 170,700 |
2018/11/15 | 3,430 | 3,440 | 3,390 | 3,420 | -30 | -0.9% | 117,800 |
2018/11/14 | 3,515 | 3,525 | 3,440 | 3,450 | -65 | -1.8% | 145,500 |
2018/11/13 | 3,530 | 3,530 | 3,485 | 3,515 | -55 | -1.5% | 201,000 |
2018/11/12 | 3,560 | 3,600 | 3,530 | 3,570 | -10 | -0.3% | 209,400 |
2018/11/09 | 3,565 | 3,630 | 3,550 | 3,580 | +20 | +0.6% | 241,900 |
2018/11/08 | 3,555 | 3,580 | 3,500 | 3,560 | +70 | +2% | 399,800 |
2018/11/07 | 3,480 | 3,525 | 3,430 | 3,490 | -170 | -4.6% | 681,800 |
2018/11/06 | 3,620 | 3,690 | 3,620 | 3,660 | +45 | +1.2% | 177,400 |
2018/11/05 | 3,575 | 3,635 | 3,575 | 3,615 | +45 | +1.3% | 231,600 |
2018/11/02 | 3,540 | 3,575 | 3,515 | 3,570 | +55 | +1.6% | 207,000 |
2018/11/01 | 3,505 | 3,560 | 3,495 | 3,515 | -5 | -0.1% | 223,400 |
2018/10/31 | 3,445 | 3,525 | 3,435 | 3,520 | +65 | +1.9% | 277,700 |
2018/10/30 | 3,375 | 3,460 | 3,370 | 3,455 | +45 | +1.3% | 922,300 |
2018/10/29 | 3,450 | 3,490 | 3,410 | 3,410 | -20 | -0.6% | 204,300 |
2018/10/26 | 3,435 | 3,450 | 3,365 | 3,430 | -5 | -0.1% | 364,500 |
2018/10/25 | 3,495 | 3,510 | 3,425 | 3,435 | -110 | -3.1% | 300,600 |
2018/10/24 | 3,570 | 3,585 | 3,515 | 3,545 | +30 | +0.9% | 217,700 |
2018/10/23 | 3,585 | 3,585 | 3,510 | 3,515 | -120 | -3.3% | 197,700 |
2018/10/22 | 3,605 | 3,655 | 3,570 | 3,635 | +10 | +0.3% | 231,400 |
2018/10/19 | 3,610 | 3,630 | 3,600 | 3,625 | +5 | +0.1% | 205,700 |
2018/10/18 | 3,650 | 3,695 | 3,610 | 3,620 | +20 | +0.6% | 268,200 |
2018/10/17 | 3,515 | 3,620 | 3,485 | 3,600 | +100 | +2.9% | 365,400 |
2018/10/16 | 3,510 | 3,550 | 3,485 | 3,500 | -45 | -1.3% | 258,900 |
2018/10/15 | 3,570 | 3,595 | 3,535 | 3,545 | -65 | -1.8% | 225,100 |
2018/10/12 | 3,700 | 3,715 | 3,600 | 3,610 | -95 | -2.6% | 266,900 |
2018/10/11 | 3,695 | 3,745 | 3,680 | 3,705 | -60 | -1.6% | 253,400 |
1551~
1600
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.66倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 437,300円 | +5.8% | +1.2% | 2.74% | 14.50倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 89,900円 | +26.8% | - | 0.00% | 15.13倍 | 3.13倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム